Critical Supply Chain And Logistics Considerations For Cell And Gene Therapy Management

In this webinar, industry leaders delve into the critical aspects of managing the temperature-controlled supply chain and logistics for cell and gene therapies (CGTs). Moderated by Dr. Mark Sawicki, CEO of Cryoport Systems, the discussion features insights from Natalie Sacarakis, Head of Cell and Gene Therapy Logistics at IQVIA, and Narinder Singh, Chief Technical Officer at Arcellx.

The panel explores the unique challenges and complexities involved in CGT logistics, focusing on key areas such as donor and patient accessibility, critical raw materials management, and the use of innovative temperature control equipment. They also address the significant regulatory requirements and the vital role of data integration and visibility in ensuring the safe and efficient delivery of these advanced therapies.

As the CGT field rapidly expands, with an increasing number of clinical and commercial programs, the conversation highlights the need for robust, scalable supply chain solutions. This discussion offers valuable perspectives for professionals involved in the development and delivery of cell and gene therapies, emphasizing the importance of innovation and collaboration in overcoming the logistical challenges of this growing industry.